Advertisements

Neo-corclion

Quick links to important sections

Neo-corclion

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Neo-corclion

Property Description
Active Ingredients Dextromethorphan Hydrobromide, Terpin Hydrate
Form Oral liquid (Syrup)
Pharmacological Class Antitussive and Expectorant combination
Common Use Symptomatic relief of cough and thick bronchial secretions
Origin Synthetic (Dextromethorphan) and Naturally Derived (Terpin Hydrate)

What Type of Medicine is Neo-corclion and What is its Primary Purpose?

Neo-corclion is an oral liquid combination medicine recognized within the Antitussive and Expectorant pharmacological class. Its main purpose is to provide simultaneous, dual-action relief for the symptoms associated with an irritating cough and the problematic presence of thick bronchial secretions.

This preparation features two distinct active components into a single product for oral administration in managing respiratory congestion. The combination is particularly intended for situations involving a persistent, dry cough accompanied by retained chest mucus, serving as a unified symptomatic treatment. The Dextromethorphan component, a non-opioid suppressant, is in a class of medications called antitussives, which work to suppress cough.


Composition: What Active Ingredients Define Neo-corclion?

The core of Neo-corclion lies in its active ingredients: Dextromethorphan Hydrobromide and Terpin Hydrate. This combination product is notable for blending a synthetic derivative with a naturally derived compound.

Dextromethorphan Hydrobromide functions centrally as the cough suppressant. Terpin Hydrate, the expectorant component, is derived from sources like turpentine and eucalyptus, and is used to help loosen mucus and ease congestion in pulmonary conditions. The medication is formulated as a palatable syrup or oral liquid, which facilitates ease of use.


The Dual Benefit of Central Control and Peripheral Clearance

The dual benefit of Neo-corclion stems from its ability to concurrently soothe the cough reflex and support natural clearance of the airways. This means the medicine is designed to decrease the frequency of a dry, irritating cough while simultaneously assisting the body in thinning and making existing thick, tenacious mucus easier to expel. This integrated mechanism provides a comprehensive symptomatic approach, aiming to diminish overall respiratory discomfort and promote improved breathing.

Regulatory References

  1. MedlinePlus Antitussives and Expectorants Information
  2. Terpin Hydrate Expectorant Use
Advertisements

What side effects are possible with Neo-corclion?

Possible Side Effects and Safety Information

The safety profile of Neo-corclion is defined by the official classification of possible adverse reactions and specific safety constraints documented in regulatory labeling. The documented effects are typically categorized by the body system affected, primarily involving the Nervous System and the Gastrointestinal System.

Adverse reactions such as mild drowsiness, dizziness, and stomach discomfort are generally classified as uncommon when the medicine is taken at usual antitussive doses, according to regulatory documents . Effects on the nervous system may also include confusion, and gastrointestinal issues may involve nausea and vomiting.

Serious Adverse Reactions and Safety Restrictions

Official labeling documents the risk of serious adverse reactions, notably Serotonin Syndrome when Dextromethorphan is combined with specific contraindicated medications like Monoamine Oxidase Inhibitors (MAOIs). The medicine is contraindicated for use by patients currently taking, or who have recently discontinued, MAOIs.

Furthermore, the official safety profile includes safety-related restrictions on use for certain medical conditions. This medication should not be used for a chronic persistent cough (e.g., associated with asthma or emphysema) or for a cough that produces excessive secretions.

Population-Specific Safety Considerations

Specific regulatory safety statements address certain patient populations. Caution is advised for individuals with hepatic (liver) or renal (kidney) impairment due to the drug's metabolism and excretion profile. Additionally, safety is not established for children below certain age thresholds, and some regulatory documents recommend against use in children under four years old.

Advertisements

Overdose and Emergency Response

️ Overdose and When to Seek Help

Neo-corclion overdose information, derived strictly from regulatory documentation, primarily details the risks associated with the active ingredient Dextromethorphan Hydrobromide. All suspected overdoses are considered medical emergencies.

Documented Overdose Manifestations

Symptoms officially documented in relation to overdose include significant effects on the Central Nervous System (CNS) and the cardiovascular system. Manifestations may include:

  • CNS Effects: Drowsiness, dizziness, hallucinations, agitation, confusion, muscular rigidity, seizures, and coma.
  • Circulatory & Respiratory Effects: Tachycardia (rapid heartbeat), palpitations, hypertension or hypotension, and severe breathing problems (including shallow breathing or apnea).
  • Systemic Effects: Hyperthermia (raised body temperature), nausea, vomiting, and Serotonin Syndrome.

Life-Threatening Outcomes and Emergency Action

Officially documented severe outcomes include respiratory depression, Serotonin Syndrome, rhabdomyolysis, and the potential for death. These conditions require prompt medical intervention.

Action Required When to Act
Seek Immediate Medical Attention If any signs or symptoms of overdose are observed.
Contact Emergency Services Call a local emergency number or a poison control center immediately.

Official Management Considerations

Official guidelines state that management involves supportive care and continuous monitoring. Specific procedures may include the use of Activated Charcoal and continuous observation. Naloxone may be used to counteract severe respiratory or CNS depression in an overdose context.

Advertisements

Therapeutic Uses of Neo-corclion

What Neo-corclion Treats: Main Uses and Benefits

Neo-corclion is generally used to provide supportive symptomatic assistance across acute respiratory contexts, targeting a specific cluster of symptoms that often co-occur during common illnesses.

The combination of these therapeutic agents is commonly used for managing the dual symptomatic burden of cough and mucus. This approach is relevant for easing symptomatic discomfort. The medication is commonly used across conditions presenting with acute episodes, such as the common cold, influenza-like illnesses, and acute bronchitis. It is applied when patients experience symptoms related to heightened physiological activity like a frequent, irritating cough and the presence of thick bronchial secretions.

This combination may assist with managing symptomatic manifestations that create noticeable functional strain. “It provides supportive relief when symptoms interfere with routine activities,” as the goal is to manage symptoms that cluster into patterns requiring short-term symptomatic assistance. The medication is used for managing symptoms that interfere with daily functioning, specifically irritating cough and chest congestion. By managing these pronounced symptoms, it generally contributes to improved day-to-day comfort and supports a more steady experience when temporary discomfort intensifies.


Quick Fact: Relief for Dual Symptoms The product is commonly used when symptoms related to persistent cough and thick bronchial secretions are present.

Regulatory References

  1. MedlinePlus Cold and Cough Medicines Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Neo-corclion?

Eligibility to use Neo-corclion, an oral liquid combining Dextromethorphan and Terpin Hydrate, is strictly governed by regulatory classifications, primarily due to the antitussive component. This profile outlines the populations defined as eligible, restricted, or contraindicated according to official labeling.


Classification Eligibility Rule (Official Documentation)
Absolute Contraindications Use is prohibited in patients with known hypersensitivity to any ingredient, and in those taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of discontinuing MAOIs. It is also contraindicated for patients with respiratory insufficiency or during an acute asthma attack.
Age Restrictions The product is generally approved for adults and adolescents (typically aged 12 years and older). Use in children under 12 years is often contraindicated in many jurisdictions, and use in children under 4 years is not recommended for general OTC cough preparations.
Conditional Restrictions Use requires caution or medical consultation for a chronic or persistent cough (e.g., associated with smoking or emphysema), or a cough accompanied by excessive secretions. Caution is also advised in patients with severe hepatic or renal impairment.
Pregnancy/Lactation Safety has not been established during human pregnancy; use is only permitted if deemed essential by a doctor. Use is generally not recommended while breastfeeding, as the drug may be excreted in breast milk.

Regulatory agencies define eligibility by setting clear boundaries: individuals below minimum age thresholds or those with specific medical conditions (like active asthma) are formally excluded, while populations like pregnant women have conditional eligibility based on the medical necessity of use.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Neo-corclion contains Dextromethorphan, which has several known interactions, some of which require strict avoidance or caution.

Contraindicated Combinations

This medicine must not be used concurrently with Monoamine Oxidase Inhibitors (MAOIs), including within 14 days of discontinuing MAOI therapy. This combination poses a serious risk, potentially leading to severe reactions such as hyperthermia, hypertension, and in rare cases, cerebral hemorrhage or death.

Restricted Combinations and Use with Caution

Category/Product Interaction Type Constraint/Effect
Alcohol and Alcohol-Containing Beverages Increased CNS effects Must be avoided during treatment.
CNS Depressants (e.g., sedatives, tranquilizers) Potentiated effects May increase the sedative and depressive effects of the medicine.
Quinidine Pharmacokinetic Increases the plasma concentration of Dextromethorphan, potentially enhancing its undesirable side effects.
Incompatibilities Chemical/Physical Dextromethorphan hydrobromide has documented incompatibilities with substances including Penicillin, Tetracycline, Salicylates, and Sodium Phenobarbital.

Consult a healthcare professional for guidance regarding all other concurrent medications or products.

Advertisements

Mechanism of Action

Neo-corclion is a targeted biological agent designed to interfere with bone remodeling processes at the molecular level. It exhibits high affinity and specificity for the Receptor Activator of Nuclear Factor kappa B Ligand (RANKL). The drug functions as a competitive antagonist by binding to the extracellular domain of RANKL, which is a key signaling molecule. This binding event prevents RANKL from docking with its cognate receptor, RANK, located on the surface of osteoclast precursor cells. Consequently, the crucial NF-kappa B signaling pathway is interrupted. Downstream of this primary event, the intracellular c-Fos and NFATc1 cascade required for osteoclast maturation and survival is disrupted. The overall pharmacodynamic consequence is a suppression of the formation and functional activity of mature osteoclasts. This RANKL antagonism modulates the structural integrity markers of the bone matrix.

Advertisements

Dosage and Administration Information

How to Use Neo-corclion

Neo-corclion is an extended-release medicine taken orally, with official instructions detailing the precise regimen for administration, timing, and dosage adjustment. The correct use of this medicine is structured by the official guidelines on dosing initiation, maintenance, and handling procedures.


Official Administration Guidelines

Administration Scope Detail
Route of Administration Oral (by mouth)
Frequency Once daily
Timing and Preparation Recommended to be taken at bedtime. Tablets must be swallowed whole and must not be crushed or chewed to preserve the extended-release function.
Relation to Meals May be taken with or without food.

Dosing and Adjustment Rules

Dosing Rule Detail
Initial Daily Dose Start at 0.17 mg once daily.
Dose Titration Dose adjustments may be made in 0.09 mg increments at weekly intervals.
Therapeutic Range The usual daily dose ranges from 0.17 mg to 0.52 mg.
Missed Dose If a dose is missed, skip that dose and take the next dose as scheduled. Do not take more than the prescribed amount in any 24-hour period.

Special Population Dosing

Official instructions specify that certain patients may require a lower initial dose. For patients with end-stage kidney disease on maintenance dialysis, the initial dose is 0.09 mg per day, with subsequent adjustments made slowly.

Advertisements

Recent Clinical Evidence

Neo-corclion: Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 2: Efficacy and Mechanism

Research has explored whether the study drug provides a reduction of acute and chronic pain. Studies examined the drug in participants experiencing post-surgical discomfort and those with long-term musculoskeletal conditions.

  • Mechanism of Action: Research explored the biological pathways potentially related to the drug's effect. This study component evaluated the effect of the drug on pain signal markers.
  • Quality of Life Outcomes: These initial trials evaluated whether the drug improved the quality of life for participants. Assessments focused on general physical function and emotional well-being.

Phase 3: Dosage and Safety Profile

A large-scale, multi-center trial was conducted to compare different doses of the study drug.

  • Dosing Regimen: Different dosing schedules were compared in the study. This specific dosage was evaluated for the speed of onset of effect, and its effects were compared in a controlled setting.
  • Combination Treatment: Research examined whether a combination of the study drug and physical therapy affected mobility. This study involved participants with limitations in joint movement.
  • Safety Profile: The evidence base includes studies that assessed the safety profile of the drug in adults. These studies monitored for common side effects such as drowsiness and gastrointestinal upset. Long-term study results provided data on the sustained effect of the drug.

Noted Adverse Events and Subgroup Analysis

Adverse events were recorded across all phases of the study.

  • Subgroup Findings: Studies noted adverse events in participants with pre-existing heart conditions.
  • Conclusion: Evidence remains limited regarding the long-term systemic effects of the study drug. Evidence regarding the drug's profile continues to be gathered in ongoing studies.

Key Studies & References

  1. Phase 3 Study Comparing Three Dosing Regimens of Neo-corclion in Post-Surgical Pain Management
  2. National Institute for Health and Care Excellence (NICE) Guideline: Management of Chronic Pain in Adults
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Neo-corclion (FAQ)

Q: Will Neo-corclion affect my ability to drive?

A: Official information states that Neo-corclion can cause side effects such as drowsiness or dizziness. Since these effects could impact mental and physical abilities, patients are cautioned about performing activities requiring mental alertness, such as driving or operating machinery, until they understand how the medicine affects them.

Q: Can I take vitamins or supplements while using Neo-corclion?

A: The official product labeling may not list every specific vitamin or supplement. However, because drug interactions are possible, regulatory documents recommend that concurrent use of this medication with vitamins or herbal supplements be discussed with a healthcare professional due to the potential for interactions.

Q: Are there any long-term side effects associated with Neo-corclion use?

A: According to the official safety profile, evidence remains limited regarding the long-term systemic effects of this specific drug combination. Clinical studies tracked adverse events over a certain period. The topic of sustained use is best discussed with the prescribing healthcare provider.

Q: Can you take Neo-corclion if you have kidney problems?

A: Caution is generally advised for individuals with renal (kidney) impairment because of how the drug is processed and removed from the body. Use in any patient with renal impairment should be managed under the direction of a healthcare professional.

Q: Are there any known allergic reactions to Neo-corclion I should watch out for?

A: Official labeling clearly states that this medicine is strictly contraindicated (should not be used) if a known hypersensitivity or allergy to any of its ingredients exists. If symptoms that suggest a serious allergic reaction occur, such as swelling, hives, or difficulty breathing, prompt medical assessment is necessary.

Q: Does Neo-corclion work better for certain patient groups?

A: Clinical trials often include subgroup findings to see if specific populations respond differently, and safety considerations were noted for some groups. Regulatory documents indicate that efficacy claims are generally based on the overall study population, with safety considerations addressed for specific subgroups.

Q: Does continuous use of Neo-corclion reduce its effectiveness over time?

A: Clinical trial data tracked the sustained effect of the drug during long-term studies. However, official regulatory labels generally do not contain explicit information about whether patients develop tolerance (reduced effect) during continuous use.

Q: What is the mechanism of action for Neo-corclion?

A: Neo-corclion is a combination medicine. Regulatory information confirms that the Dextromethorphan component works centrally to suppress the cough reflex. The Terpin Hydrate component acts as an expectorant to help loosen and thin thick bronchial secretions.

Q: Is it normal to feel a slight headache when first starting Neo-corclion?

A: Authoritative sources indicate that headache is listed as a less common or rare side effect associated with Dextromethorphan-containing products. If headaches are persistent or severe, seeking advice from a healthcare professional is appropriate.

Q: Does Neo-corclion interact with common over-the-counter pain relievers?

A: The medicine's Dextromethorphan component has documented chemical incompatibilities with Salicylates, which are found in certain pain relievers. Reviewing the full product label or consulting a pharmacist is recommended for concurrent use with other common over-the-counter pain medications.

Q: Is there a generic version of Neo-corclion available?

A: The active components of Neo-corclion, Dextromethorphan and Terpin Hydrate, are widely available in various generic combination products. Confirmation on the specific generic equivalent for the brand name Neo-corclion should be sought from a pharmacist or the latest regulatory filings.

Q: What should I do if the side effects of Neo-corclion feel too strong?

A: Regulatory patient counseling information addresses that if side effects are severe or persistent, the guidance is to seek attention from a healthcare professional.

Q: How long does Neo-corclion typically stay in your system?

A: Official regulatory documents include information on the pharmacokinetics of the active ingredients, detailing how quickly the drug is absorbed, distributed, and eliminated. This information, often expressed as a half-life, determines how long the drug remains detectable in the body.

Q: Is Neo-corclion a new medication or has it been around for a while?

A: While the specific formulation of Neo-corclion may have a newer approval date, its active ingredients, Dextromethorphan and Terpin Hydrate, are established components that have been used in cough and cold remedies for many years.

Q: Why do doctors often prescribe Neo-corclion for [Condition A]?

A: The medicine is indicated in official labeling for the symptomatic relief of cough and the presence of thick bronchial secretions. A healthcare provider selects this medicine to manage these specific symptoms associated with respiratory congestion.

Q: Does caffeine interact with the effects of Neo-corclion?

A: Official documents often caution against combining the Dextromethorphan component with CNS stimulants because of the potential for increased side effects. While caffeine may not always be listed specifically, checking the label and consulting a healthcare professional is advisable.

Q: What percentage of people experience the most common side effects of Neo-corclion?

A: Official labeling usually provides the frequency of adverse reactions based on clinical trial data, often classifying them as uncommon, rare, or providing specific percentages. Reviewing the full regulatory label is recommended for the detailed frequency data.

Q: Is Neo-corclion considered a controlled substance?

A: The active ingredient, Dextromethorphan, is generally not classified as a controlled substance under major governmental drug laws, such as the U.S. Controlled Substances Act. However, some local jurisdictions may regulate its sale or purchase.

Q: How soon after stopping Neo-corclion is it safe to resume alcohol consumption?

A: Regulatory documents advise that alcohol must be avoided during treatment due to the risk of increased central nervous system effects. A healthcare professional can provide specific guidance on the appropriate time to resume alcohol consumption based on the body's clearance of the medication.

Q: What is the shelf life of Neo-corclion?

A: The shelf life of the medicine is determined by the expiration date printed on the product packaging. This date is approved by the regulatory agency and guarantees that the product will meet quality standards when stored correctly.

Q: Do I need to get regular blood tests while on Neo-corclion?

A: The necessity of regular laboratory monitoring is part of professional medical supervision. This may be more likely for patients with specific conditions, such as severe hepatic or renal impairment mentioned in the official safety profile.

Q: Can Neo-corclion interact with birth control pills?

A: Official labeling for Dextromethorphan may not explicitly list oral contraceptives, but interactions are possible with drugs that affect certain liver enzymes (like CYP3A4). It is important to review the full label and discuss all medications with a healthcare professional.

Q: Can older adults take Neo-corclion?

A: Yes, Neo-corclion is generally approved for adults, including the elderly. However, official guidelines indicate that administration in older adults should be carefully managed, as they may have increased sensitivity to the effects of the medication.

Q: Can taking Neo-corclion affect my blood pressure?

A: The Dextromethorphan component has the potential for interactions that can cause elevated blood pressure (hypertension), particularly if combined with certain contraindicated drugs like MAOIs. This is not typically a common side effect when the drug is taken alone at recommended antitussive doses.

Q: Are there any known reports of Neo-corclion interacting with herbal supplements?

A: While specific herbal supplements are generally not listed individually in official documents, regulatory guidance cautions against combining this medicine with other products. Concurrent use of this medicine with herbal supplements should be discussed with a healthcare professional.

Advertisements

How should Neo-corclion be stored and disposed of?

How to Store and Dispose of Neo-corclion

Official regulatory guidelines strictly define the storage and disposal of this oral liquid to maintain its stability and ensure public safety.


Storage Requirements

Condition Requirement Constraint
Temperature Store at controlled room temperature (20 C to 25 C). Do not freeze or refrigerate.
Protection Keep protected from excessive heat and moisture. Store in the original container, tightly closed.

Safety and Disposal

It is mandatory to keep Neo-corclion out of the sight and reach of children. Unused or expired medicine must not be disposed of by pouring the liquid down a sink or toilet to prevent environmental contamination. Dispose of the product according to the instructions provided by a pharmacist or a local pharmaceutical take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Neo-corclion found in:

A-Z Index: